Last10K.com

Monterey Innovation Acquisition Corp (MTRY) SEC Filing 10-Q Quarterly Report for the period ending Friday, June 30, 2023

Monterey Bio Acquisition Corp

HISTORY TOOLS
CIK: 1860663 Ticker: MTRY
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Aug. 21, 2023
Document Entity Information  
Document Type10-Q 
Document Quarterly Reporttrue 
Document Period End DateJun. 30, 2023 
Document Transition Reportfalse 
Entity File Number001-40861 
Entity Registrant NameMONTEREY INNOVATION ACQUISITION CORP. 
Entity Incorporation, State or Country CodeDE 
Entity Tax Identification Number85-2204842 
Entity Address, Address Line One17 State Street 
Entity Address, Address Line Two21st Floor 
Entity Address, City or TownNew York 
Entity Address State Or ProvinceNY 
Entity Address, Postal Zip Code10004 
City Area Code917 
Local Phone Number267-0216 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Entity Ex Transition Periodfalse 
Entity Shell Companytrue 
Entity Common Stock, Shares Outstanding 4,335,930
Entity Central Index Key0001860663 
Current Fiscal Year End Date--12-31 
Document Fiscal Year Focus2023 
Document Fiscal Period FocusQ2 
Amendment Flagfalse 
Transition Reportfalse 
Common Stock, par value $0.0001 per share  
Document Entity Information  
Title of 12(b) SecurityCommon Stock, par value $0.0001 per share 
Trading SymbolMTRY 
Security Exchange NameNASDAQ 
Redeemable Warrants, each Warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share  
Document Entity Information  
Title of 12(b) SecurityRedeemable Warrants, each Warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share 
Trading SymbolMTRYW 
Security Exchange NameNASDAQ 
Units, each consisting of one share of Common Stock and one redeemable Warrant  
Document Entity Information  
Title of 12(b) SecurityUnits, each consisting of one share of Common Stock and one redeemable Warrant 
Trading SymbolMTRYU 
Security Exchange NameNASDAQ 

View differences made from one quarter to another to evaluate Monterey Bio Acquisition Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Monterey Bio Acquisition Corp.

Continue

Assess how Monterey Bio Acquisition Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Monterey Bio Acquisition Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Condensed Statements Of Cash Flows
Condensed Statements Of Changes In Stockholders' (Deficit) Equity
Condensed Statements Of Operations
Commitments And Contingencies
Commitments And Contingencies (Details)
Commitments And Contingencies - Contingent Fee Arrangements (Details)
Commitments And Contingencies - Related Party Transactions (Details)
Description Of Organization, Business Operations, Liquidity, And Risks And Uncertainties
Description Of Organization, Business Operations, Liquidity, And Risks And Uncertainties (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Schedule Of Company's Assets That Are Measured At Fair Value On A Recurring Basis (Details)
Related Party Transactions
Related Party Transactions - Additional Information (Details)
Related Party Transactions - Founder Shares (Details)
Stockholders' Deficit
Stockholders' Deficit - Common Stock Shares (Details)
Stockholders' Deficit - Preferred Stock Shares (Details)
Stockholders' Deficit- Warrants (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Reconciliation Of Net Loss Per Common Stock (Details)
Summary Of Significant Accounting Policies - Summary Of Reconciliation Of Common Stock Reflected On The Balance Sheet (Details)
Ticker: MTRY
CIK: 1860663
Form Type: 10-Q Quarterly Report
Accession Number: 0001410578-23-002043
Submitted to the SEC: Mon Aug 21 2023 7:00:25 PM EST
Accepted by the SEC: Tue Aug 22 2023
Period: Friday, June 30, 2023
Industry: Blank Checks

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mtry/0001410578-23-002043.htm